Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Meeks

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
The New England Journal of Medicine|September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder CancerThomas Powles, James W F Catto, Matthew D Galsky, et al.
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder CancerDavid J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
The New England Journal of Medicine|September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder CancerThomas Powles, James W F Catto, Matthew D Galsky, et al.
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder CancerDavid J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Pageof 21